Background:
Cancer and its treatment can reduce long-term cognitive functioning, leading to symptoms such as confusion, poor motor coordination, and memory difficulties.
While it is well established that exercise has many benefits for cancer survivors, few studies have looked at the relationship between cognitive function and exercise.
This study will help researchers learn more about how to design exercise programs and deliver them at the right time to help manage some of the symptoms experienced by metastatic kidney cancer survivors.
The Trial:
Participation in this study will involve assessments completed at two time points. A baseline assessment when you begin the study and a followup assessment taken three months later from the comfort of your home.
At each time point you will be asked to complete the following tasks:
- Complete a cognitive functioning test that will measure your memory, attention and processing speed.
- A 6-minute walking test. No prior physical activity experience will be needed to complete this test.
- Wear an activity monitor for seven days during your usual waking hours.
You will also be compensated $60 for your participation in both assessment sessions
Basic Eligibility:
- At least 18 years old
- Kidney cancer that has spread beyond the kidney
- Currently receiving any systemic therapy for kidney cancer (Sunitinib (Sutent®), Nivolumab (Opdivo®), etc.)
Additional eligibility criteria may apply. Please speak to your doctor.
Find out more about his study
Hospital / Cancer Centre | Principal Investigator | Location | Trial Status |
---|---|---|---|
Hospital / Cancer CentreUniversity of Toronto | Principal InvestigatorDr. Linda Trinh | LocationToronto, ON | Trial StatusRecruiting |